{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:34Z","timestamp":1791323674235,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.seizure.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:17:12Z","timestamp":1788995832000},"page":"240-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vigabatrin-associated brain MRI abnormalities in children: Associations with drug exposure and epilepsy etiology"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-6857","authenticated-orcid":false,"given":"Hyoung Won","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-8065","authenticated-orcid":false,"given":"Zhulin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Prestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Sankhla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","article-title":"Vigabatrin: 2008 update","volume":"50","author":"Willmore","year":"2009","journal-title":"Epilepsia"},{"issue":"24","key":"10.1016\/j.seizure.2026.09.006_bib0002","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","volume":"78","author":"Go","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.seizure.2026.09.006_bib0003","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1528-1157.1999.tb01599.x","article-title":"Characteristics of a unique visual field defect attributed to vigabatrin","volume":"40","author":"Wild","year":"1999","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2026.09.006_bib0004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200124050-00005","article-title":"Visual field defects and other ophthalmological disturbances associated with vigabatrin","volume":"24","author":"Spence","year":"2001","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","article-title":"Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy","volume":"50","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.crad.2023.11.010","article-title":"The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis","volume":"79","author":"Corr\u00eaa","year":"2024","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.seizure.2026.09.006_bib0008","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.13712","article-title":"Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent","volume":"58","author":"Hussain","year":"2017","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2026.09.006_bib0009","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1528-1167.2010.02564.x","article-title":"Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms","volume":"51","author":"Dracopoulos","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/019262339001800201","article-title":"Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor","volume":"18","author":"Gibson","year":"1990","journal-title":"Toxicol Pathol"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0011","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/019262338701500203","article-title":"A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats","volume":"15","author":"Butler","year":"1987","journal-title":"Toxicol Pathol"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1528-1157.2000.tb00134.x","article-title":"The potential for vigabatrin-induced intramyelinic edema in humans","volume":"41","author":"Cohen","year":"2000","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2026.09.006_bib0013","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/epi.17121","article-title":"Risk of vigabatrin-associated brain abnormalities on MRI: a retrospective and controlled study","volume":"63","author":"Xu","year":"2022","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0014","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0000000000000433","article-title":"Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment","volume":"30","author":"Symonds","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2026.09.006_bib0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/epi.16755","article-title":"Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: a systematic review and meta-analysis","volume":"62","author":"Stefanski","year":"2021","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2026.09.006_bib0016","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jmedgenet-2015-103263","article-title":"Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis","volume":"53","author":"Trump","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.seizure.2026.09.006_bib0017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pediatrneurol.2025.12.001","article-title":"Vigabatrin-associated Brain Magnetic Resonance imaging abnormalities in two children with WW domain-containing oxidoreductase-related Epileptic Encephalopathy Syndrome","volume":"175","author":"Choi","year":"2026","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/0004-282x20170192","article-title":"Globus pallidus restricted diffusion associated with vigabatrin therapy","volume":"76","author":"Trindade","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"10.1016\/j.seizure.2026.09.006_bib0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2026.09.006_bib0021","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1471-4159.1977.tb10721.x","article-title":"gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice","volume":"29","author":"Jung","year":"1977","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.seizure.2026.09.006_bib0022","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/dmcn.12976","article-title":"GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy","volume":"58","author":"Papandreou","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"10.1016\/j.seizure.2026.09.006_bib0023","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1111\/jnc.15932","article-title":"GABAA receptors in epilepsy: elucidating phenotypic divergence through functional analysis of genetic variants","volume":"168","author":"Absalom","year":"2024","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.seizure.2026.09.006_bib0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1535-7511.2008.01278.x","article-title":"Molecular pathology of genetic epilepsies associated with GABAA receptor subunit mutations","volume":"9","author":"Macdonald","year":"2009","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2026.09.006_bib0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainres.2019.03.004","article-title":"A structural look at GABAA receptor mutations linked to epilepsy syndromes","volume":"1714","author":"Hernandez","year":"2019","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0030","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0031","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/epi.17841","article-title":"Mechanisms of infantile epileptic spasms syndrome: what have we learned from animal models?","volume":"65","author":"Ng","year":"2024","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.09.006_bib0026","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-8749.2007.02017.x","article-title":"Transient magnetic resonance diffusion abnormalities in West syndrome: the radiological expression of non-convulsive status epilepticus?","volume":"50","author":"Desguerre","year":"2008","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.seizure.2026.09.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214181","article-title":"Pearls & oy-sters: acute obstructive hydrocephalus Co-occurrence with vigabatrin-associated MRI changes in an infant with LIS1-related classical lissencephaly","volume":"105","author":"Gamber","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.09.006_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pediatrneurol.2016.10.004","article-title":"Neuroimaging abnormalities in a child with infantile spasms on high-dose Vigabatrin","volume":"67","author":"Sun","year":"2017","journal-title":"Pediatr Neurol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:48:53Z","timestamp":1791323333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S1059131126002700"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.09.006","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vigabatrin-associated brain MRI abnormalities in children: Associations with drug exposure and epilepsy etiology","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}